Company intelligence / Profile preview

Expert.ai

Modena, Italy

Ownership: Private
Development stage: Other

Overview

Expert.ai has launched multiple AI solutions (e.g., EIX-Submission Readiness, EIX-Preclinical Document Intelligence, EIX-Clinical Trials Intelligence, EIX-IP Detection) that streamline research, preclinical documentation, clinical trial design, and regulatory processes for pharma, life sciences, and healthcare customers. Solutions deliver greater regulatory accuracy, more efficient trial design, and enhance R&D productivity, as validated by adoption at leading organizations like Sanofi and recognition at industry events (e.g., Bio-IT World Best of Show finalist).

Industry: Drug Discovery Services

Partnerships

SanofiNew England Journal of MedicineINSERMEBSCO3M Health

Beyond the preview

Go deeper on Expert.ai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Expert.ai.

Explore the full profile